9/11/2020CMSC INforMS: New Data Further Reinforce Genentech’s Ocrevus (ocrelizumab) as Effective Treatment
8/24/2020CMSC INforMS: PRESS RELEASE - GENENTECH'S ENSPRYNG FOR NEUROMYELITIS OPTICA SPECTRUM DISORDER
8/19/2020CMSC INforMS: Mylan Brings Critical Access to the MS Community
7/11/2020CMSC INforMS: A Letter from Lemtrada Regarding its Home Phlebotomy Partner, EMSI
7/8/2020WHO and AMA statement
6/2/2021 » 6/5/2021
2021 CMSC Annual Meeting (San Diego, CA)
Print Page